5.4.1 Consolidated statement of income

(in millions of euros) Notes 2014 2013 restated(7)
Sales 4.1
12,725
11,662
Cost of sales 4.3
(10,522)
(9,653)
GROSS MARGIN 4.3
2,203
2,009
% of sales
17.3%
17.2%
Research and Development expenditure, net 4.51
(685)
(614)
Selling expenses
(207)
(193)
Administrative expenses
(449)
(436)
Operating margin
862
766
% of sales
6.8%
6.6%
Share in net earnings of equity-accounted companies 4.5 3.1
51
26
Operating margin including share in net earnings
of equity-accounted companies
4.5
913
792
XBRL logo
These samples have been prepared by XBRL International as a technology demonstration, and the accuracy of figures and information contained within this sample should not be relied upon for any purpose whatsoever.
5493006IH2N2WMIBB742 2014-01-01 2014-12-31 5493006IH2N2WMIBB742 2013-01-01 2013-12-31 iso4217:EUR